Clinical Trial Update: Efficacy and Safety of Apatinib for Recurrent or Metastatic Esophageal Squamous Cell Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial update on apatinib for recurrent or metastatic esophageal squamous cell carcinoma showing efficacy and safety results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Neoplasms

Drugs mentioned

• Apatinib (apatinib)

Snippet

Sponsor: Fudan University | Conditions: Esophageal Neoplasms | Phase 2 | Status: COMPLETED